FDA chief Gottlieb is building a regulatory speedway to accelerate gene therapy development – Endpoints News
Endpoints News |
FDA chief Gottlieb is building a regulatory speedway to accelerate gene therapy development
Endpoints News Gottlieb discussed the FDA's policy plans for gene therapy Tuesday at the annual board meeting of the Alliance for Regenerative Medicine. Quoting an MIT study that predicts 40 FDA-approved gene therapy products by the end of 2022, he acknowledged … Gene Therapies That Could Transform Diseases Get Easier FDA … FDA plans to speed path to approval for some gene therapies – Stat Gene therapies get easier path to FDA approval |
